We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMLP icon
4851
Martin Midstream Partners
MMLP
$97.8M
$32K ﹤0.01%
2,254
-1,152
-34% -$17.3K
MVIS icon
4852
Microvision
MVIS
$86.9M
$32K ﹤0.01%
+1,299
New +$37.5K
TIPT icon
4853
Tiptree Inc
TIPT
$673M
$32K ﹤0.01%
+5,410
New +$35.3K
ZYNE
4854
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$32K ﹤0.01%
2,516
+2,016
+403% +$23.1K
AMBR
4855
DELISTED
Amber Road Inc
AMBR
$32K ﹤0.01%
+4,328
New +$32.3K
MACK
4856
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$32K ﹤0.01%
4,038
+3,631
+892% +$33.9K
DRYS
4857
DELISTED
DryShips Inc. Common Stock
DRYS
$32K ﹤0.01%
+8,944
New +$34.1K
BLRX
4858
BioLineRX
BLRX
$11.8M
$31K ﹤0.01%
+48
New +$31.6K
CLSD
4859
DELISTED
Clearside Biomedical
CLSD
$31K ﹤0.01%
+297
New +$31.9K
EML icon
4860
Eastern Company
EML
$149M
$31K ﹤0.01%
+1,204
New +$34.1K
LPCN icon
4861
Lipocine
LPCN
$17.3M
$31K ﹤0.01%
533
-797
-60% -$49.6K
MBIN icon
4862
Merchants Bancorp
MBIN
$2.48B
$31K ﹤0.01%
+2,349
New +$29.3K
NATR icon
4863
Nature's Sunshine
NATR
$277M
$31K ﹤0.01%
2,704
+2,433
+898% +$27.7K
PCYO icon
4864
Pure Cycle
PCYO
$270M
$31K ﹤0.01%
+3,692
New +$27.8K
PDS
4865
Precision Drilling
PDS
$1.05B
$31K ﹤0.01%
518
-14,903
-97% -$816K
PEBK icon
4866
Peoples Bancorp of North Carolina
PEBK
$228M
$31K ﹤0.01%
+1,006
New +$31.6K
SOL
4867
DELISTED
Emeren Group
SOL
$31K ﹤0.01%
11,665
+11,307
+3,158% +$32.1K
UBFO
4868
DELISTED
United Security Bancshares
UBFO
$31K ﹤0.01%
+2,817
New +$27.9K
KMF
4869
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
$31K ﹤0.01%
2,259
-45
-2% -$606
MIE
4870
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$31K ﹤0.01%
3,036
-500
-14% -$4.91K
LTM
4871
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$31K ﹤0.01%
2,200
-63,424
-97% -$849K
KTEC
4872
DELISTED
Key Technology Inc
KTEC
$31K ﹤0.01%
+1,700
New +$30.4K
CLFD icon
4873
Clearfield
CLFD
$391M
$30K ﹤0.01%
+2,482
New +$33.4K
ESSA
4874
DELISTED
ESSA Bancorp
ESSA
$30K ﹤0.01%
+1,920
New +$30.3K
FRI icon
4875
First Trust S&P REIT Index Fund
FRI
$201M
$30K ﹤0.01%
1,291

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.